#labmeeting #totallyrandom

Our latest paper with John Haran and Sam McLean, "Association between microbiome and the development of adverse posttraumatic neuropsychiatric sequelae after traumatic stress exposure " has just been published online! rdcu.be/drtEG. Huge shoutout to Abigail Zeamer!

Making #presepio with Nonni. Another tradition to pass down…

One of the most renowned British legends is the tale of King Arthur and the sword in the stone. As the story goes, only the true king of England could extract the sword from the stone. Interestingly, a lesser-known but similar story can be found in Tuscany, Italy, and some even

😍💜⚜️ #ForzaViola #FiorentinaTorino #ACFFiorentina #seriea

Our new paper is out! Another great collaboration with @MichaelGlickma1 Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption | Science Translational Medicine science.org/doi/10.1126/sc…

Commensal bacteria in the gut #microbiome display surprising resilience to #antibiotics, evolve resistance mutations, and reestablish a healthy biome after treatment, shows a 20-month long study of patients with #tuberculosis. Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 @MichaelGlickma1 scim.ag/5A0

Microbiota encoded fatty-acid metabolism expands tuft cells to protect tissues homeostasis during Clostridioides difficile infection in the large intestine biorxiv.org/content/10.110… new preprint from the lab. Finalizing experiments for full paper reviews.. Reboldi Lab

Microbiota time! 🦠 #PreprintHub2 w/ Catherine Shelton Mariana Byndloss and 愛理沙 will discuss a #preprint on how microbial FA metabolism expands tuft cells to protect tissues homeostasis during C. difficile infection Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 Reboldi Lab 🐭👇 biorxiv.org/content/10.110…

Why are some non-antibiotic drugs toxic to bacteria 💊☠️🦠? Do they work like standard #antibiotics (ABX)? Our latest work by Mariana Noto published Science Magazine addresses this fundamental question (1/n) science.org/doi/10.1126/sc…

Drug-resistant tuberculosis: a persistent global health concern nature.com/articles/s4157… Ahead of #WorldTBDay this weekend, Pai (@paimadhu) & co review the global landscape of drug-resistant TB, its causes, risk factors, impact, latest diagnostics, treatments, and more.

Early-onset colorectal cancer is expected to become the leading cause of #cancer death in ages 20 to 49 in the U.S. by 2030. Research is urgently needed to better detect and treat patients, argues this #SciencePerspective: scim.ag/6pk #ColorectalCancerAwarenessMonth

Playing #Juventus is always a difficult game for Torino Football Club who don't have Juve's money, but the Torino people always have hope - In bocca al Lupo al Toro Sabado - #ForzaToro Sempre...

TIME's list of the 100 Most Influential People in the world is out. I'm honored, delighted, and grateful to be a part of this incredible group #TIME100 🙏🏼🙏🏼🙏🏼 TIME time.com/6964230/akiko-…

Looking to learn more about the #microbiome? Come along to #FOGBoston and hear from Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 (Associate Professor, Microbiology and Physiological Systems, UMass Chan Medical School). Register now: hubs.la/Q02sq1c70

Just came back from Memorial Day at Harvard Bookstore. Will have some fun reads for the next couple of months…

Vedanta Biosciences To Present at IDWeek 2024 on Benefit of VE303 on Antibiotic Resistant Gene Levels in Patient Microbiomes businesswire.com/news/home/2024…

The Vedanta team is very excited to share our latest findings coming out of our successful VE303 Ph2 study in CDI. #IDWeek2024

Olive picking at home…#bluezone

In Journal of Experimental Medicine, Reboldi Lab Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 et al. reveal that #microbiome-driven tuft cells’ hyperplasia in the colon helps defend against Clostridioides difficile infection, providing a pathway thru which host & microbial interactions protect against pathogens hubs.la/Q02ZBWxx0